Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01930032 · ClinicalTrials.gov registry record
Pathogenic Mechanisms in C Diff Infection and Colitis
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT01930032: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT01930032 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01930032 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness ranging from mild diarrhea to severe colitis (infection of the colon). C. difficile makes toxins that damage the cells that line the colon. The study doctors want to find out how these toxins cause damage to the cells in the colon.
Primary Outcome
As assessed by confocal fluorescence microscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-01 |
What the finished NCT01930032 record still lists
NCT01930032 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01930032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01930032 about?
NCT01930032 is a clinical study titled "Pathogenic Mechanisms in C Diff Infection and Colitis". The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness r...
What is the current status of trial NCT01930032?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-08. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01930032?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia